nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—HDAC2—oviduct—uterine cancer	0.0467	0.105	CbGeAlD
Oxtriphylline—Caffeine—PIK3CA—uterine cancer	0.0305	1	CrCbGaD
Oxtriphylline—HDAC2—exocrine gland—uterine cancer	0.027	0.0607	CbGeAlD
Oxtriphylline—HDAC2—Teniposide—Etoposide—uterine cancer	0.0168	0.731	CbGdCrCtD
Oxtriphylline—ADORA2B—smooth muscle tissue—uterine cancer	0.0159	0.0358	CbGeAlD
Oxtriphylline—ADORA2B—decidua—uterine cancer	0.0156	0.0351	CbGeAlD
Oxtriphylline—ADORA2B—mammalian vulva—uterine cancer	0.0143	0.0323	CbGeAlD
Oxtriphylline—PDE4A—decidua—uterine cancer	0.0139	0.0313	CbGeAlD
Oxtriphylline—SLC22A7—renal system—uterine cancer	0.0127	0.0285	CbGeAlD
Oxtriphylline—PDE3A—smooth muscle tissue—uterine cancer	0.0117	0.0264	CbGeAlD
Oxtriphylline—HDAC2—epithelium—uterine cancer	0.0117	0.0264	CbGeAlD
Oxtriphylline—HDAC2—uterine cervix—uterine cancer	0.0116	0.0262	CbGeAlD
Oxtriphylline—HDAC2—smooth muscle tissue—uterine cancer	0.0113	0.0254	CbGeAlD
Oxtriphylline—PDE4D—female gonad—uterine cancer	0.0113	0.0253	CbGeAlD
Oxtriphylline—ADORA2B—vagina—uterine cancer	0.0111	0.025	CbGeAlD
Oxtriphylline—HDAC2—decidua—uterine cancer	0.0111	0.0249	CbGeAlD
Oxtriphylline—ADORA1—renal system—uterine cancer	0.011	0.0248	CbGeAlD
Oxtriphylline—HDAC2—renal system—uterine cancer	0.0109	0.0245	CbGeAlD
Oxtriphylline—HDAC2—endometrium—uterine cancer	0.0105	0.0237	CbGeAlD
Oxtriphylline—ADORA2A—female reproductive system—uterine cancer	0.0102	0.023	CbGeAlD
Oxtriphylline—PDE4A—female gonad—uterine cancer	0.00996	0.0224	CbGeAlD
Oxtriphylline—HDAC2—uterus—uterine cancer	0.0097	0.0218	CbGeAlD
Oxtriphylline—PDE3A—female reproductive system—uterine cancer	0.00906	0.0204	CbGeAlD
Oxtriphylline—ADORA1—female reproductive system—uterine cancer	0.00883	0.0198	CbGeAlD
Oxtriphylline—HDAC2—female reproductive system—uterine cancer	0.00872	0.0196	CbGeAlD
Oxtriphylline—PDE4B—uterine cervix—uterine cancer	0.00871	0.0196	CbGeAlD
Oxtriphylline—PDE3B—lymph node—uterine cancer	0.00867	0.0195	CbGeAlD
Oxtriphylline—PDE4B—decidua—uterine cancer	0.0083	0.0187	CbGeAlD
Oxtriphylline—PDE3A—female gonad—uterine cancer	0.00824	0.0185	CbGeAlD
Oxtriphylline—ADORA1—vagina—uterine cancer	0.00798	0.018	CbGeAlD
Oxtriphylline—HDAC2—female gonad—uterine cancer	0.00793	0.0178	CbGeAlD
Oxtriphylline—HDAC2—vagina—uterine cancer	0.00789	0.0177	CbGeAlD
Oxtriphylline—PDE4B—endometrium—uterine cancer	0.00788	0.0177	CbGeAlD
Oxtriphylline—PDE4B—mammalian vulva—uterine cancer	0.00762	0.0171	CbGeAlD
Oxtriphylline—PDE4D—lymph node—uterine cancer	0.00724	0.0163	CbGeAlD
Oxtriphylline—PDE4B—female reproductive system—uterine cancer	0.00653	0.0147	CbGeAlD
Oxtriphylline—PDE4A—lymph node—uterine cancer	0.00641	0.0144	CbGeAlD
Oxtriphylline—HDAC2—Levonorgestrel—Progesterone—uterine cancer	0.0062	0.269	CbGdCrCtD
Oxtriphylline—PDE4B—female gonad—uterine cancer	0.00594	0.0134	CbGeAlD
Oxtriphylline—PDE4B—vagina—uterine cancer	0.0059	0.0133	CbGeAlD
Oxtriphylline—PDE3A—lymph node—uterine cancer	0.0053	0.0119	CbGeAlD
Oxtriphylline—ADORA1—lymph node—uterine cancer	0.00516	0.0116	CbGeAlD
Oxtriphylline—HDAC2—lymph node—uterine cancer	0.0051	0.0115	CbGeAlD
Oxtriphylline—CYP1A2—renal system—uterine cancer	0.00501	0.0113	CbGeAlD
Oxtriphylline—PDE4B—lymph node—uterine cancer	0.00382	0.00859	CbGeAlD
Oxtriphylline—HDAC2—Signaling Pathways—IGF1R—uterine cancer	0.000175	0.000349	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SOCS3—uterine cancer	0.000175	0.000349	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—PIK3CA—uterine cancer	0.000175	0.000348	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—NRAS—uterine cancer	0.000174	0.000347	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—ESR1—uterine cancer	0.000173	0.000344	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—PIK3CA—uterine cancer	0.000171	0.000342	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—NRAS—uterine cancer	0.000171	0.000342	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—KRAS—uterine cancer	0.000169	0.000338	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—TP53—uterine cancer	0.000169	0.000337	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—ESR1—uterine cancer	0.000168	0.000335	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CDKN2B—uterine cancer	0.000168	0.000334	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CCL2—uterine cancer	0.000167	0.000334	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—SMAD3—uterine cancer	0.000165	0.000328	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—NRAS—uterine cancer	0.000163	0.000325	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IGF1R—uterine cancer	0.000163	0.000324	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CCL2—uterine cancer	0.000162	0.000323	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—CXCL8—uterine cancer	0.000162	0.000323	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—HRAS—uterine cancer	0.000162	0.000322	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—ESR1—uterine cancer	0.000162	0.000322	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—ESR1—uterine cancer	0.00016	0.000318	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CCL2—uterine cancer	0.00016	0.000318	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—NRAS—uterine cancer	0.000159	0.000316	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—FGFR2—uterine cancer	0.000157	0.000313	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—PIK3CA—uterine cancer	0.000156	0.000312	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—PIK3CA—uterine cancer	0.000156	0.00031	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—KRAS—uterine cancer	0.000155	0.000308	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SMAD3—uterine cancer	0.000153	0.000305	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—ERBB2—uterine cancer	0.000153	0.000305	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—NRAS—uterine cancer	0.000153	0.000304	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CCL2—uterine cancer	0.000152	0.000303	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—PIK3CA—uterine cancer	0.000152	0.000302	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—NRAS—uterine cancer	0.000151	0.000301	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—KRAS—uterine cancer	0.00015	0.000299	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—PIK3CA—uterine cancer	0.000149	0.000297	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CCL2—uterine cancer	0.000148	0.000295	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—KRAS—uterine cancer	0.000148	0.000294	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—CXCL8—uterine cancer	0.000147	0.000293	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—FGFR2—uterine cancer	0.000146	0.000291	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CXCL8—uterine cancer	0.000145	0.000289	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—HRAS—uterine cancer	0.000144	0.000287	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—AKT1—uterine cancer	0.000143	0.000285	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CCL2—uterine cancer	0.000142	0.000284	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—PIK3CA—uterine cancer	0.000142	0.000283	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—PIK3CA—uterine cancer	0.000142	0.000283	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CDKN1B—uterine cancer	0.000142	0.000282	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—STAR—uterine cancer	0.000141	0.000281	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—AKR1B1—uterine cancer	0.000141	0.000281	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—ERBB2—uterine cancer	0.000141	0.00028	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CCL2—uterine cancer	0.000141	0.00028	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—KRAS—uterine cancer	0.00014	0.00028	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—AKT1—uterine cancer	0.00014	0.000279	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—ERBB2—uterine cancer	0.00014	0.000278	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000139	0.000278	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—PIK3CA—uterine cancer	0.000138	0.000275	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—PIK3CA—uterine cancer	0.000138	0.000275	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—KRAS—uterine cancer	0.000137	0.000272	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—PIK3CA—uterine cancer	0.000136	0.00027	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—ERBB2—uterine cancer	0.000135	0.00027	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—ESR1—uterine cancer	0.000134	0.000268	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CTNNB1—uterine cancer	0.000134	0.000267	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—ERBB2—uterine cancer	0.000133	0.000265	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—PIK3CA—uterine cancer	0.000133	0.000265	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CXCL8—uterine cancer	0.000132	0.000264	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—KRAS—uterine cancer	0.000132	0.000262	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—PIK3CA—uterine cancer	0.000131	0.000262	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—HRAS—uterine cancer	0.000131	0.000262	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—PTEN—uterine cancer	0.00013	0.00026	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—CDKN1B—uterine cancer	0.00013	0.00026	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—KRAS—uterine cancer	0.00013	0.000259	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CDKN1B—uterine cancer	0.000129	0.000258	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—PIK3CA—uterine cancer	0.000129	0.000257	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CXCL8—uterine cancer	0.000128	0.000256	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—AKT1—uterine cancer	0.000128	0.000255	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—HRAS—uterine cancer	0.000128	0.000254	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—AKT1—uterine cancer	0.000127	0.000253	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—ERBB2—uterine cancer	0.000127	0.000252	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CXCL8—uterine cancer	0.000126	0.000252	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—PIK3CA—uterine cancer	0.000126	0.00025	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—HRAS—uterine cancer	0.000125	0.00025	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CDKN1B—uterine cancer	0.000125	0.00025	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—ESR1—uterine cancer	0.000125	0.000249	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—EP300—uterine cancer	0.000124	0.000248	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—AKT1—uterine cancer	0.000124	0.000247	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CDKN1B—uterine cancer	0.000123	0.000246	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—ERBB2—uterine cancer	0.000123	0.000246	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—CTNNB1—uterine cancer	0.000123	0.000245	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CTNNB1—uterine cancer	0.000122	0.000243	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—AKT1—uterine cancer	0.000122	0.000243	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—PIK3CA—uterine cancer	0.000121	0.000241	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CXCL8—uterine cancer	0.00012	0.000239	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PTEN—uterine cancer	0.00012	0.000239	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—PIK3CA—uterine cancer	0.000119	0.000238	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—HRAS—uterine cancer	0.000119	0.000238	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—PTEN—uterine cancer	0.000119	0.000237	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—ERBB2—uterine cancer	0.000119	0.000236	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CTNNB1—uterine cancer	0.000118	0.000236	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCL2—uterine cancer	0.000118	0.000236	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—NRAS—uterine cancer	0.000118	0.000235	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—VEGFA—uterine cancer	0.000118	0.000235	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CDKN1B—uterine cancer	0.000117	0.000234	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—ERBB2—uterine cancer	0.000117	0.000234	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CXCL8—uterine cancer	0.000117	0.000233	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CTNNB1—uterine cancer	0.000116	0.000232	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—NRAS—uterine cancer	0.000116	0.000232	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—HRAS—uterine cancer	0.000116	0.000231	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—AKT1—uterine cancer	0.000116	0.000231	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—AKT1—uterine cancer	0.000116	0.000231	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—PTEN—uterine cancer	0.000115	0.00023	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—EP300—uterine cancer	0.000114	0.000228	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CDKN1B—uterine cancer	0.000114	0.000227	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—PTEN—uterine cancer	0.000114	0.000226	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—EP300—uterine cancer	0.000113	0.000226	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—AKT1—uterine cancer	0.000113	0.000225	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—AKT1—uterine cancer	0.000113	0.000224	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CXCL8—uterine cancer	0.000113	0.000224	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—HRAS—uterine cancer	0.000112	0.000223	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CXCL8—uterine cancer	0.000111	0.000222	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CTNNB1—uterine cancer	0.000111	0.000221	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—AKT1—uterine cancer	0.000111	0.000221	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—POLD1—uterine cancer	0.000111	0.00022	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—HRAS—uterine cancer	0.00011	0.00022	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—EP300—uterine cancer	0.00011	0.000219	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCL2—uterine cancer	0.00011	0.000219	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CDKN1B—uterine cancer	0.00011	0.000219	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—AKT1—uterine cancer	0.000109	0.000217	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CDKN1B—uterine cancer	0.000109	0.000216	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—EP300—uterine cancer	0.000108	0.000216	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—PTEN—uterine cancer	0.000108	0.000215	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CTNNB1—uterine cancer	0.000108	0.000215	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—VEGFA—uterine cancer	0.000107	0.000214	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—AKT1—uterine cancer	0.000107	0.000214	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—NRAS—uterine cancer	0.000107	0.000213	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—NRAS—uterine cancer	0.000106	0.000212	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—AKT1—uterine cancer	0.000105	0.00021	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—PTEN—uterine cancer	0.000105	0.000209	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—VEGFA—uterine cancer	0.000104	0.000208	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CTNNB1—uterine cancer	0.000104	0.000207	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—AKR1C1—uterine cancer	0.000103	0.000206	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—EP300—uterine cancer	0.000103	0.000205	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—NRAS—uterine cancer	0.000103	0.000205	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—PIK3CA—uterine cancer	0.000103	0.000205	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CTNNB1—uterine cancer	0.000103	0.000204	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—AKT1—uterine cancer	0.000103	0.000204	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—VEGFA—uterine cancer	0.000103	0.000204	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—KRAS—uterine cancer	0.000102	0.000202	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—NRAS—uterine cancer	0.000101	0.000202	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—PTEN—uterine cancer	0.000101	0.000202	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—EP300—uterine cancer	0.0001	0.0002	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—KRAS—uterine cancer	0.0001	0.0002	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—PTEN—uterine cancer	0.0001	0.000199	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—AKT1—uterine cancer	9.87e-05	0.000197	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—ERBB2—uterine cancer	9.85e-05	0.000196	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—VEGFA—uterine cancer	9.76e-05	0.000194	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—AKT1—uterine cancer	9.75e-05	0.000194	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—EP300—uterine cancer	9.65e-05	0.000192	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—NRAS—uterine cancer	9.64e-05	0.000192	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—EP300—uterine cancer	9.53e-05	0.00019	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—VEGFA—uterine cancer	9.49e-05	0.000189	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—NRAS—uterine cancer	9.38e-05	0.000187	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CXCL8—uterine cancer	9.34e-05	0.000186	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—PIK3CA—uterine cancer	9.33e-05	0.000186	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—RRM2—uterine cancer	9.22e-05	0.000184	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—KRAS—uterine cancer	9.21e-05	0.000184	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—PIK3CA—uterine cancer	9.2e-05	0.000183	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—ERBB2—uterine cancer	9.16e-05	0.000183	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—VEGFA—uterine cancer	9.14e-05	0.000182	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—KRAS—uterine cancer	9.14e-05	0.000182	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CDKN1B—uterine cancer	9.13e-05	0.000182	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—VEGFA—uterine cancer	9.03e-05	0.00018	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—NRAS—uterine cancer	9.03e-05	0.00018	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—DCN—uterine cancer	8.95e-05	0.000178	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—NRAS—uterine cancer	8.92e-05	0.000178	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TP53—uterine cancer	8.9e-05	0.000177	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—KRAS—uterine cancer	8.86e-05	0.000177	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—KRAS—uterine cancer	8.72e-05	0.000174	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CXCL8—uterine cancer	8.69e-05	0.000173	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—HRAS—uterine cancer	8.63e-05	0.000172	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CTNNB1—uterine cancer	8.62e-05	0.000172	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—HRAS—uterine cancer	8.51e-05	0.00017	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CDKN1B—uterine cancer	8.48e-05	0.000169	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PIK3CA—uterine cancer	8.46e-05	0.000169	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP11A1—uterine cancer	8.43e-05	0.000168	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PTEN—uterine cancer	8.4e-05	0.000167	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—PIK3CA—uterine cancer	8.39e-05	0.000167	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—AKT1—uterine cancer	8.39e-05	0.000167	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—KRAS—uterine cancer	8.3e-05	0.000165	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—PIK3CA—uterine cancer	8.14e-05	0.000162	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TP53—uterine cancer	8.12e-05	0.000162	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—KRAS—uterine cancer	8.07e-05	0.000161	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CTNNB1—uterine cancer	8.01e-05	0.00016	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—EP300—uterine cancer	8.01e-05	0.00016	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—PIK3CA—uterine cancer	8.01e-05	0.00016	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—AKR1C3—uterine cancer	7.96e-05	0.000159	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TP53—uterine cancer	7.88e-05	0.000157	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—HRAS—uterine cancer	7.83e-05	0.000156	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PTEN—uterine cancer	7.81e-05	0.000156	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—KRAS—uterine cancer	7.77e-05	0.000155	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—HRAS—uterine cancer	7.77e-05	0.000155	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TP53—uterine cancer	7.75e-05	0.000154	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—KRAS—uterine cancer	7.68e-05	0.000153	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—PIK3CA—uterine cancer	7.62e-05	0.000152	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—AKT1—uterine cancer	7.62e-05	0.000152	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—VEGFA—uterine cancer	7.59e-05	0.000151	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—HRAS—uterine cancer	7.53e-05	0.00015	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—AKT1—uterine cancer	7.51e-05	0.00015	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NRAS—uterine cancer	7.5e-05	0.000149	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—EP300—uterine cancer	7.45e-05	0.000148	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—AKT1—uterine cancer	7.45e-05	0.000148	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—PIK3CA—uterine cancer	7.41e-05	0.000148	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—HRAS—uterine cancer	7.41e-05	0.000148	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TP53—uterine cancer	7.37e-05	0.000147	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TP53—uterine cancer	7.17e-05	0.000143	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—PIK3CA—uterine cancer	7.14e-05	0.000142	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—VEGFA—uterine cancer	7.06e-05	0.000141	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—PIK3CA—uterine cancer	7.05e-05	0.000141	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—HRAS—uterine cancer	7.05e-05	0.000141	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NRAS—uterine cancer	6.97e-05	0.000139	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—AKT1—uterine cancer	6.92e-05	0.000138	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TP53—uterine cancer	6.9e-05	0.000138	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—HRAS—uterine cancer	6.86e-05	0.000137	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—AKT1—uterine cancer	6.86e-05	0.000137	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TP53—uterine cancer	6.82e-05	0.000136	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—AKT1—uterine cancer	6.65e-05	0.000133	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—HRAS—uterine cancer	6.6e-05	0.000132	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—AKT1—uterine cancer	6.54e-05	0.00013	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—HRAS—uterine cancer	6.53e-05	0.00013	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—KRAS—uterine cancer	6.45e-05	0.000129	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—AKT1—uterine cancer	6.23e-05	0.000124	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—STK11—uterine cancer	6.2e-05	0.000124	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP19A1—uterine cancer	6.2e-05	0.000124	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—AKT1—uterine cancer	6.06e-05	0.000121	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—KRAS—uterine cancer	6e-05	0.00012	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PIK3CA—uterine cancer	5.93e-05	0.000118	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—AKT1—uterine cancer	5.83e-05	0.000116	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.82e-05	0.000116	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—AKT1—uterine cancer	5.76e-05	0.000115	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TP53—uterine cancer	5.73e-05	0.000114	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.55e-05	0.000111	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PIK3CA—uterine cancer	5.51e-05	0.00011	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—HRAS—uterine cancer	5.48e-05	0.000109	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TP53—uterine cancer	5.33e-05	0.000106	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—HRAS—uterine cancer	5.1e-05	0.000102	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—AKT1—uterine cancer	4.84e-05	9.65e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—MTHFR—uterine cancer	4.66e-05	9.29e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—AKT1—uterine cancer	4.5e-05	8.97e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.11e-05	8.18e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PTEN—uterine cancer	2.59e-05	5.17e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—EP300—uterine cancer	2.47e-05	4.93e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.83e-05	3.64e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—AKT1—uterine cancer	1.49e-05	2.98e-05	CbGpPWpGaD
